journal article·2025-12-26

Mn–Ce Synergy Promoting Defective Hollow CeO 2 Nanospheres Amplifies the ROS Storm for Tumor Therapy

Jie Yao, Jianxin Feng, Haoliang Ruan, Chengyi Li, La Pan, Bei Wei, Rongrong Xing, Shurong Ban, Li Tang, Bin Liu

ACS Applied Nano Materials· Volume 8· Issue 51
Publisher page

Abstract

The regulation of the valence states and surface vacancy defect concentrations is crucial for enhancing the catalytic activity of cerium-based nanozymes. Herein, Mn-doped cerium dioxide hollow nanospheres with a mesoporous surface (denoted as M-CeMn 0.5 ) were synthesized using a tannic acid chelation and sacrificial template method. The mesoporous surface structure of the M-CeMn 0.5 nanozymes provides abundant active sites for catalytic reactions. Results indicate that the synergistic effect between Mn and Ce promotes the generation of increased Ce 3+ species and oxygen vacancies on the CeO 2 surface. Furthermore, Mn doping enhances the electron transfer rate during catalysis, which ensures excellent peroxidase (POD)-like activity of M-CeMn 0.5 in both chemical and cellular environments. Moreover, in vitro experiments demonstrated that M-CeMn 0.5 catalyzes the decomposition of H 2 O 2 in the tumor microenvironment (TME) into • OH and • O 2 – via a Fenton-like reaction. This process resulted in a killing efficiency of 65.6% against MCF-7 cells while also exhibiting good biosafety. This study provides a strategy for developing efficient and safe nanozymes and improves the efficacy of metal oxide nanozymes in combination cancer therapy.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Advanced Nanomaterials in Catalysis · Nanoplatforms for cancer theranostics · Catalytic Processes in Materials Science

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Medicinal Basic Research Innovation Center of Chronic Kidney Disease of Ministry of Education, School of Pharmacy

Shanxi Medical University

School of Basic Medical Science

Academy of Medical Sciences

Shanxi Provincial Key Laboratory of Drug Synthesis and Novel Pharmaceutical Preparation Technology

Funding

Shanxi Provincial Education Department · Natural Science Foundation of Shanxi Province · National Natural Science Foundation of China

References (50)

Show source-provided references
1. 10.1016/j.ccr.2021.21417010.1016/j.ccr.2021.214170 ↗
2. 10.1016/j.trac.2024.11781510.1016/j.trac.2024.117815 ↗
3. 10.1016/j.foodchem.2024.13901910.1016/j.foodchem.2024.139019 ↗
4. 10.1016/j.nantod.2023.10179810.1016/j.nantod.2023.101798 ↗
5. 10.1021/acsnano.4c0122910.1021/acsnano.4c01229 ↗
6. 10.2147/IJN.S46604210.2147/IJN.S466042 ↗
7. 10.1002/adfm.20241483710.1002/adfm.202414837 ↗
8. 10.1007/s11426-023-1677-410.1007/s11426-023-1677-4 ↗
9. 10.1039/D1NR04196G10.1039/D1NR04196G ↗
10. 10.1002/adma.20241967310.1002/adma.202419673 ↗
11. 10.1002/advs.20230742410.1002/advs.202307424 ↗
12. 10.1016/j.cej.2025.16129610.1016/j.cej.2025.161296 ↗
13. 10.3390/inorganics1212033110.3390/inorganics12120331 ↗
14. 10.1021/acsami.4c0079310.1021/acsami.4c00793 ↗
15. 10.1021/acsnano.3c0878010.1021/acsnano.3c08780 ↗
16. 10.1039/D5NR00430F10.1039/D5NR00430F ↗
17. 10.1016/j.ccr.2022.21464910.1016/j.ccr.2022.214649 ↗
18. 10.1021/acsanm.2c0300910.1021/acsanm.2c03009 ↗
19. 10.1016/j.jre.2020.06.01910.1016/j.jre.2020.06.019 ↗
20. 10.1016/j.envres.2022.11396110.1016/j.envres.2022.113961 ↗
21. 10.1002/smll.20220340010.1002/smll.202203400 ↗
22. 10.1039/b922024k10.1039/b922024k ↗
23. 10.1039/b919677n10.1039/b919677n ↗
24. 10.1021/acsami.1c1082110.1021/acsami.1c10821 ↗
25. 10.1002/advs.20230715410.1002/advs.202307154 ↗
26. 10.1002/adhm.20220173310.1002/adhm.202201733 ↗
27. 10.1002/adfm.20190706610.1002/adfm.201907066 ↗
28. 10.1016/j.surfin.2024.10384610.1016/j.surfin.2024.103846 ↗
29. 10.1016/j.cclet.2023.10911410.1016/j.cclet.2023.109114 ↗
30. 10.1016/j.apsusc.2019.14429510.1016/j.apsusc.2019.144295 ↗
31. 10.1016/j.jallcom.2024.17521010.1016/j.jallcom.2024.175210 ↗
32. 10.1007/s12274-022-4360-010.1007/s12274-022-4360-0 ↗
33. 10.1016/j.jtice.2022.10456010.1016/j.jtice.2022.104560 ↗
34. 10.1016/j.cej.2021.12996810.1016/j.cej.2021.129968 ↗
35. 10.1002/anie.20221099110.1002/anie.202210991 ↗
36. 10.1007/s00604-023-06129-810.1007/s00604-023-06129-8 ↗
37. 10.1016/j.jhazmat.2020.12408810.1016/j.jhazmat.2020.124088 ↗
38. 10.1016/j.snb.2018.05.10810.1016/j.snb.2018.05.108 ↗
39. 10.1016/j.talanta.2025.12758610.1016/j.talanta.2025.127586 ↗
40. 10.1021/acs.inorgchem.3c0009510.1021/acs.inorgchem.3c00095 ↗
41. 10.1016/j.seppur.2024.12699310.1016/j.seppur.2024.126993 ↗
42. 10.1021/acscatal.3c0623410.1021/acscatal.3c06234 ↗
43. 10.1039/C6TB00422A10.1039/C6TB00422A ↗
44. 10.1016/j.apsusc.2020.14601310.1016/j.apsusc.2020.146013 ↗
45. 10.1021/acs.langmuir.4c0284210.1021/acs.langmuir.4c02842 ↗
46. 10.1021/acs.analchem.2c0251110.1021/acs.analchem.2c02511 ↗
47. 10.1016/j.apsusc.2021.15065410.1016/j.apsusc.2021.150654 ↗
48. 10.1016/j.colsurfa.2021.12765110.1016/j.colsurfa.2021.127651 ↗
49. 10.26599/NR.2025.9490706310.26599/NR.2025.94907063 ↗
50. 10.26599/NR.2025.9490706310.26599/NR.2025.94907063 ↗